0000915913-22-000139.txt : 20220901 0000915913-22-000139.hdr.sgml : 20220901 20220901161253 ACCESSION NUMBER: 0000915913-22-000139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220831 FILED AS OF DATE: 20220901 DATE AS OF CHANGE: 20220901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crawford Raphael Goszcz CENTRAL INDEX KEY: 0001776484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12658 FILM NUMBER: 221221090 MAIL ADDRESS: STREET 1: 4311 GREENBRIAR HILLS PLANTATION RD CITY: CHARLOTTE STATE: NC ZIP: 28277 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBEMARLE CORP CENTRAL INDEX KEY: 0000915913 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 541692118 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4250 CONGRESS STREET STREET 2: SUITE 900 CITY: CHARLOTTE STATE: NC ZIP: 28209 BUSINESS PHONE: 980-299-5700 MAIL ADDRESS: STREET 1: 4250 CONGRESS STREET STREET 2: SUITE 900 CITY: CHARLOTTE STATE: NC ZIP: 28209 FORMER COMPANY: FORMER CONFORMED NAME: ECHEM INC DATE OF NAME CHANGE: 19931208 4 1 wf-form4_166206315260917.xml FORM 4 X0306 4 2022-08-31 0 0000915913 ALBEMARLE CORP ALB 0001776484 Crawford Raphael Goszcz ALBEMARLE CORPORATION 4250 CONGRESS STREET, SUITE 900 CHARLOTTE NC 28209 0 1 0 0 President, Catalysts Common Stock 2022-08-31 4 M 0 7218 91 A 25914 D Common Stock 2022-08-31 4 S 0 7218 268.28 D 18696 D Common Stock 2022-08-31 4 S 0 320 271.24 D 18376 D Common Stock 2022-08-31 4 S 0 2839 21.59 D 15537 D Common Stock 2022-08-31 4 S 0 7591 270.20 D 7946 D Stock Option 91.0 2022-08-31 4 M 0 7218 0 D 2022-02-26 2029-02-25 Common Stock 7218.0 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.05 to $269.65, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. On February 26, 2019, the reporting person was granted a 10-year option exercisable for 7,218 shares of Common Stock. The option cliff-vested on 2/26/2022. /s/ Stefanie M. Holland, Attorney-in-Fact 2022-09-01